Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs1051169
rs1051169
0.010 GeneticVariation BEFREE Stratified analyses showed that the rs1051169 polymorphism was associated with an increased risk of neurologic disorder in SLE patients (C vs. G: OR=1.78, 95% CI, 1.22-2.59, p=0.003; GC vs. GG: OR=2.33, 95% CI, 1.14-4.77, P=0.019; CC vs. GG: OR=3.02, 95% CI, 1.39-6.53, p=0.004; CC+GC vs. GG: OR=2.57, 95% CI=1.31-5.04, p=0.005). 31271591

2020

dbSNP: rs12720270
rs12720270
0.010 GeneticVariation BEFREE SLE protection was associated with TYK2 risk infection variants affecting residually its catalytic domain, rs12720356 (OR = 0.308; p = 0.041) and rs34536443 (OR = 0.370; p = 0.034), but not with rs2304256, rs12720270, and rs280500. 31434951

2019

dbSNP: rs12720356
rs12720356
0.010 GeneticVariation BEFREE SLE protection was associated with TYK2 risk infection variants affecting residually its catalytic domain, rs12720356 (OR = 0.308; p = 0.041) and rs34536443 (OR = 0.370; p = 0.034), but not with rs2304256, rs12720270, and rs280500. 31434951

2019

dbSNP: rs2304256
rs2304256
0.010 GeneticVariation BEFREE SLE protection was associated with TYK2 risk infection variants affecting residually its catalytic domain, rs12720356 (OR = 0.308; p = 0.041) and rs34536443 (OR = 0.370; p = 0.034), but not with rs2304256, rs12720270, and rs280500. 31434951

2019

dbSNP: rs280500
rs280500
0.010 GeneticVariation BEFREE SLE protection was associated with TYK2 risk infection variants affecting residually its catalytic domain, rs12720356 (OR = 0.308; p = 0.041) and rs34536443 (OR = 0.370; p = 0.034), but not with rs2304256, rs12720270, and rs280500. 31434951

2019

dbSNP: rs28362930
rs28362930
0.010 GeneticVariation BEFREE The allele frequency of G (rs28362930) was higher in S</span>LE patients with renal disorder. 31394943

2019

dbSNP: rs34536443
rs34536443
0.010 GeneticVariation BEFREE SLE protection was associated with TYK2 risk infection variants affecting residually its catalytic domain, rs12720356 (OR = 0.308; p = 0.041) and rs34536443 (OR = 0.370; p = 0.034), but not with rs2304256, rs12720270, and rs280500. 31434951

2019

dbSNP: rs741761
rs741761
0.010 GeneticVariation BEFREE There were differences in the genotype frequencies and allele frequencies of rs741761 between SLE patients with and without arthritis. 31394943

2019

dbSNP: rs3824662
rs3824662
0.010 GeneticVariation BEFREE GATA3 rs3824662 is not associated with susceptibility to SLE either in adult or in pediatric patients; however, in pSLE patients, the heterozygous AC genotype could be considered a risk factor for LN. 30301440

2018

dbSNP: rs13277113
rs13277113
BLK
0.010 GeneticVariation BEFREE We observed more frequent heterozygous GA genotypic pattern (rs13277113) in our SLE patients compared to that in controls; and it was associated with disease flares. 27864698

2017

dbSNP: rs3077
rs3077
0.010 GeneticVariation BEFREE In conclusion, HLA-DP polymorphisms (rs3077 and rs9277535) were associated with SLE susceptibility and the levels of some inflammatory cytokines in SLE patients. 28094303

2017

dbSNP: rs9277535
rs9277535
0.010 GeneticVariation BEFREE In conclusion, HLA-DP polymorphisms (rs3077 and rs9277535) were associated with SLE susceptibility and the levels of some inflammatory cytokines in SLE patients. 28094303

2017

dbSNP: rs2397084
rs2397084
0.010 GeneticVariation BEFREE IL-17A rs2275913, IL-17F rs763780 and rs2397084 are not related to the LN development, SLE disease activity or overall survival. 26515887

2016

dbSNP: rs2736340
rs2736340
0.010 GeneticVariation BEFREE SLE was associated with frequency of rs548234 (P = 0.010; odds ratio [OR] = 1.298), rs2736340 (P = 2.47 × 10<sup>-5</sup> ; OR = 1.574) and rs10516487 (P = 0.002; OR = 0.642). 26420661

2016

dbSNP: rs548234
rs548234
0.010 GeneticVariation BEFREE SLE was associated with frequency of rs548234 (P = 0.010; odds ratio [OR] = 1.298), rs2736340 (P = 2.47 × 10<sup>-5</sup> ; OR = 1.574) and rs10516487 (P = 0.002; OR = 0.642). 26420661

2016

dbSNP: rs3805455
rs3805455
0.010 GeneticVariation BEFREE Additional analysis showed that the genotype of the rs929763 and rs3805455 of the GABRP gene were also significantly associated with female SLE patients (P < 0.0001, P = 0.005, resp.). 26634217

2015

dbSNP: rs4581
rs4581
0.010 GeneticVariation BEFREE Val/Leu247 polymorphism of β2-glycoprotein I and thrombosis in Chinese patients with SLE. 24661363

2015

dbSNP: rs929763
rs929763
0.010 GeneticVariation BEFREE Additional analysis showed that the genotype of the rs929763 and rs3805455 of the GABRP gene were also significantly associated with female SLE patients (P < 0.0001, P = 0.005, resp.). 26634217

2015

dbSNP: rs2243188
rs2243188
0.010 GeneticVariation BEFREE The minor C allele of rs2243188, relative to the major A allele, appeared to have a significantly lower frequency in SLE patients (31.0%) as compared with controls (35.5%) (χ(2) = 5.19, p = 0.023). 24819332

2014

dbSNP: rs231775
rs231775
0.010 GeneticVariation BEFREE The CTLA4 +49 A/G (rs231775) polymorphism influences susceptibility to SLE in South Indian Tamils. 24758310

2014

dbSNP: rs10489265
rs10489265
0.010 GeneticVariation BEFREE To replicate the association, two single-nucleotide polymorphisms (SNPs: rs2205960 and rs10489265) were genotyped in 814 SLE patients. 23936824

2013

dbSNP: rs7574865
rs7574865
0.010 GeneticVariation BEFREE Furthermore, the stratified meta-analysis also demonstrate that the STAT4 rs7574865 polymorphism is associated with the presence of autoantibodies with systemic reactivity (anti-ds-DNA antibodies) in SLE patients (OR = 1.37; 95% CI = 1.21 - 1.56, P = 1.12 × 10(-6)). 23628400

2013

dbSNP: rs17266594
rs17266594
0.010 GeneticVariation BEFREE This study implies that rs10516487 and rs17266594 polymorphisms might contribute to individual susceptibility to SLE and influence the ANA/SSA autoantibody response in SLE patients in Chinese population. 21078628

2011

dbSNP: rs2910164
rs2910164
0.010 GeneticVariation BEFREE The G and C allele frequencies of rs2</span>910164 were 39 and 61% in SLE patients, but 36 and 64% in healthy group (P = 0.990), respectively. 20845080

2011

dbSNP: rs3746444
rs3746444
0.010 GeneticVariation BEFREE The C and T allele frequencies of rs3746444 were 15 and 85% in SLE patients, but 14 and 86% in healthy group (P = 0.702), respectively. 20845080

2011